#Japan #Tokyo #Integriculture #Cell Agriculture #CulNet

Integriculture Achieves Profitability by 2025

Integriculture Inc., headquartered in Bunkyo, Tokyo, has announced that it will achieve annual profitability by the fiscal year ending September 2025, which encompasses the period from October 2024 to September 2025. This groundbreaking achievement comes as the global cell agriculture market transitions from research and development to commercialization. Leveraging its unique business model, Integriculture has successfully established a sustainable growth foundation in this burgeoning industry.

Overview of Revenue Structure: Balanced Growth Through Two Main Business Pillars

The company’s revenue structure is characterized by a balanced contribution from two primary segments: the “Cell Agriculture Products Business” and the “Cell Agriculture Infrastructure Business,” each accounting for approximately 50% of total sales.

1. Cell Agriculture Products: Market Penetration of CellAg® Cosmetics

In the Cell Agriculture Products Business, which primarily centers on cosmetics OEM (original equipment manufacturer), there has been a notable increase in the adoption of the CellAg® cosmetics line, made from the company's proprietary cell culture supernatants derived from skin cell research. This growth signals a significant market acceptance and showcases the effectiveness of their innovative approach to cosmetic products.

2. Cell Agriculture Infrastructure: Implementation of Next-Gen Technologies and Diversification

The Infrastructure Business aims to create a world where everyone can practice cell agriculture. It has achieved substantial milestones from upstream to downstream operations.

• - Upstream: Commercialization of Next-Generation Technologies

Thanks to collaboration with member companies of the CulNet Consortium, technologies have moved into the commercialization phase, including the CulNet practical machine which self-manufactures serum substitutes, a “contamination-suppressing culture medium,” and an innovative “oxygen-permeable bioreactor” which addresses challenges related to dissolved oxygen supply in large-scale cultures.

• - Downstream: Value Creation Through Cell Agriculture

In addition to developing and launching cell agriculture products, their contract research organization (CRO) services are steadily advancing product commercialization efforts. A novel initiative is their partnership with sake breweries, merging traditional fermentation techniques with cutting-edge cell agriculture, which aims to create new regional business opportunities and promote cross-industry societal implementation.

Comments from CEO Yuki Hanyu

CEO Yuki Hanyu remarked, “We have successfully demonstrated that 'cell agriculture for everyone,' a vision we have championed since our inception, is not merely an ideal but a feasible business model. This return to profitability is evidence that our technology has moved beyond the laboratory and is now functioning within actual industries. We will continue to accelerate both infrastructure provisioning and product development, contributing to the resolution of food and resource challenges.”

About Integriculture Inc.

Integriculture Inc. is a startup dedicated to establishing a universal infrastructure for cell agriculture, aiming to enable the societal implementation of various cell agricultural products, including food, cosmetics, and materials. By harnessing technology that allows for low-cost cell cultivation, the company is committed to building a sustainable future through collaboration with domestic and international enterprises.

For Inquiries

For more information, please contact the Public Relations department at Integriculture Inc. via email at [email protected].